Viewing Study NCT03035058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-05-18 @ 12:10 PM
Study NCT ID: NCT03035058
Status: WITHDRAWN
Last Update Posted: 2017-03-08
First Post: 2017-01-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease
Sponsor: Takeda
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Sclerosing Cholangitis View
None Inflammatory Bowel Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View